Home
About Aglaia
Team
Investments
Impact / ESG
News
Archive
Contact
Investors login
Menu
Home
About Aglaia
Team
Investments
Impact / ESG
News
Archive
Contact
Investors login
Menu
News: 2013
News
Archive
News
Genmab A/S acquires Aglaia portfolio company Merus N.V. in US $ 8 billion all cash transaction
December 12, 2025
News Release Genmab to Acquire Merus, Expanding Late-Stage Pipeline in an all-cash transaction representing a transaction valu...
More news
Home
>
News
>
Archive
Contact
Businesspark Berg en Bosch
Prof. Bronkhorstlaan 10, building 92
3723 MB Bilthoven
T +31 (0)30 - 229 60 90
F +31 (0)30 - 229 60 99
info@aglaia-oncology.com
Aglaia Management B.V. is registered with the Trade Register of the Chamber of Commerce and Industry under number 54970857.
© 2026 Aglaia Oncology Funds
|
Privacy
|
Sitemap
